Neuroprotection Market Research Report by Product (Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists, Metal Ion Chelators, and Neurotrophic Factors), by Treatment (Alzheimer's disease, Amyotrophic lateral sclerosis, Brain injury, Huntington's disease, and Multiple sclerosis), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Neuroprotection Market is expected to grow from USD 11,234.69 Million in 2020 to USD 17,151.24 Million by the end of 2025.
2. The Global Neuroprotection Market is expected to grow from EUR 9,850.78 Million in 2020 to EUR 15,038.53 Million by the end of 2025.
3. The Global Neuroprotection Market is expected to grow from GBP 8,757.37 Million in 2020 to GBP 13,369.29 Million by the end of 2025.
4. The Global Neuroprotection Market is expected to grow from JPY 1,199,026.14 Million in 2020 to JPY 1,830,472.29 Million by the end of 2025.
5. The Global Neuroprotection Market is expected to grow from AUD 16,314.26 Million in 2020 to AUD 24,905.88 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Neuroprotection to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Neuroprotection Market studied across Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists, Metal Ion Chelators, Neurotrophic Factors, Radical Trapping Agents, and Stimulants.
Based on Treatment, the Neuroprotection Market studied across Alzheimer's disease, Amyotrophic lateral sclerosis, Brain injury, Huntington's disease, Multiple sclerosis, Neuropathies, Ocular degeneration, and Parkinson's disease.
Based on Application, the Neuroprotection Market studied across Prevention and Treatment.
Based on Geography, the Neuroprotection Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Neuroprotection Market including Allergan plc, AstraZeneca plc, Astrocyte Pharmaceuticals Inc., Biogen Inc., Daiichi Sankyo Company, Limited, Dr. Reddy's Laboratories, Eli Lilly and Company, Novartis AG, and Roche Holding AG.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Neuroprotection Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Neuroprotection Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neuroprotection Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neuroprotection Market?
4. What is the competitive strategic window for opportunities in the Global Neuroprotection Market?
5. What are the technology trends and regulatory frameworks in the Global Neuroprotection Market?
6. What are the modes and strategic moves considered suitable for entering the Global Neuroprotection Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Neuroprotection Market is expected to grow from USD 11,234.69 Million in 2020 to USD 17,151.24 Million by the end of 2025.
2. The Global Neuroprotection Market is expected to grow from EUR 9,850.78 Million in 2020 to EUR 15,038.53 Million by the end of 2025.
3. The Global Neuroprotection Market is expected to grow from GBP 8,757.37 Million in 2020 to GBP 13,369.29 Million by the end of 2025.
4. The Global Neuroprotection Market is expected to grow from JPY 1,199,026.14 Million in 2020 to JPY 1,830,472.29 Million by the end of 2025.
5. The Global Neuroprotection Market is expected to grow from AUD 16,314.26 Million in 2020 to AUD 24,905.88 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Neuroprotection to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Neuroprotection Market studied across Apoptosis Inhibitors, Free Anti-Inflammatory Agents, Glutamate Antagonists, Metal Ion Chelators, Neurotrophic Factors, Radical Trapping Agents, and Stimulants.
Based on Treatment, the Neuroprotection Market studied across Alzheimer's disease, Amyotrophic lateral sclerosis, Brain injury, Huntington's disease, Multiple sclerosis, Neuropathies, Ocular degeneration, and Parkinson's disease.
Based on Application, the Neuroprotection Market studied across Prevention and Treatment.
Based on Geography, the Neuroprotection Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Neuroprotection Market including Allergan plc, AstraZeneca plc, Astrocyte Pharmaceuticals Inc., Biogen Inc., Daiichi Sankyo Company, Limited, Dr. Reddy's Laboratories, Eli Lilly and Company, Novartis AG, and Roche Holding AG.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Neuroprotection Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Neuroprotection Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neuroprotection Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neuroprotection Market?
4. What is the competitive strategic window for opportunities in the Global Neuroprotection Market?
5. What are the technology trends and regulatory frameworks in the Global Neuroprotection Market?
6. What are the modes and strategic moves considered suitable for entering the Global Neuroprotection Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Application Outlook
3.5. Treatment Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing drug development in the pharmaceutical and biotechnology owing to increasing occurrences of traumatic brain injury
5.1.1.2. Growing incidences of CNS diseases coupled with increasing awareness
5.1.1.3. Increased demand for target-specific drug treatment for neurodegenerative diseases along with favorable government regulations
5.1.1.4. Increasing healthcare infrastructure and increasing economic stability in developing economies, such as Latin America and Middle East & Africa
5.1.2. Restraints
5.1.2.1. Limited awareness in developing economies
5.1.3. Opportunities
5.1.3.1. New product launch, investment in R&D, and increasing drug discovery & product launch
5.1.3.2. Increasing use of neuroprotection in cosmetics
5.1.3.3. Increasing use of herbal extract free-radical trapping agents such as cannabidiol, Vitamins E and C
5.1.4. Challenges
5.1.4.1. High cost associated with neuro treatments
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL NEUROPROTECTION MARKET, BY PRODUCT
6.1. Introduction
6.2. Apoptosis Inhibitors
6.3. Free Anti-Inflammatory Agents
6.4. Glutamate Antagonists
6.5. Metal Ion Chelators
6.6. Neurotrophic Factors
6.7. Radical Trapping Agents
6.8. Stimulants
7. GLOBAL NEUROPROTECTION MARKET, BY TREATMENT
7.1. Introduction
7.2. Alzheimer's disease
7.3. Amyotrophic lateral sclerosis
7.4. Brain injury
7.5. Huntington's disease
7.6. Multiple sclerosis
7.7. Neuropathies
7.8. Ocular degeneration
7.9. Parkinson's disease
8. GLOBAL NEUROPROTECTION MARKET, BY APPLICATION
8.1. Introduction
8.2. Prevention
8.3. Treatment
9. AMERICAS NEUROPROTECTION MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC NEUROPROTECTION MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Allergan plc
13.2. AstraZeneca plc
13.3. Astrocyte Pharmaceuticals Inc.
13.4. Biogen Inc.
13.5. Daiichi Sankyo Company, Limited
13.6. Dr. Reddy's Laboratories
13.7. Eli Lilly and Company
13.8. Novartis AG
13.9. Roche Holding AG
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Application Outlook
3.5. Treatment Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing drug development in the pharmaceutical and biotechnology owing to increasing occurrences of traumatic brain injury
5.1.1.2. Growing incidences of CNS diseases coupled with increasing awareness
5.1.1.3. Increased demand for target-specific drug treatment for neurodegenerative diseases along with favorable government regulations
5.1.1.4. Increasing healthcare infrastructure and increasing economic stability in developing economies, such as Latin America and Middle East & Africa
5.1.2. Restraints
5.1.2.1. Limited awareness in developing economies
5.1.3. Opportunities
5.1.3.1. New product launch, investment in R&D, and increasing drug discovery & product launch
5.1.3.2. Increasing use of neuroprotection in cosmetics
5.1.3.3. Increasing use of herbal extract free-radical trapping agents such as cannabidiol, Vitamins E and C
5.1.4. Challenges
5.1.4.1. High cost associated with neuro treatments
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL NEUROPROTECTION MARKET, BY PRODUCT
6.1. Introduction
6.2. Apoptosis Inhibitors
6.3. Free Anti-Inflammatory Agents
6.4. Glutamate Antagonists
6.5. Metal Ion Chelators
6.6. Neurotrophic Factors
6.7. Radical Trapping Agents
6.8. Stimulants
7. GLOBAL NEUROPROTECTION MARKET, BY TREATMENT
7.1. Introduction
7.2. Alzheimer's disease
7.3. Amyotrophic lateral sclerosis
7.4. Brain injury
7.5. Huntington's disease
7.6. Multiple sclerosis
7.7. Neuropathies
7.8. Ocular degeneration
7.9. Parkinson's disease
8. GLOBAL NEUROPROTECTION MARKET, BY APPLICATION
8.1. Introduction
8.2. Prevention
8.3. Treatment
9. AMERICAS NEUROPROTECTION MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC NEUROPROTECTION MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Allergan plc
13.2. AstraZeneca plc
13.3. Astrocyte Pharmaceuticals Inc.
13.4. Biogen Inc.
13.5. Daiichi Sankyo Company, Limited
13.6. Dr. Reddy's Laboratories
13.7. Eli Lilly and Company
13.8. Novartis AG
13.9. Roche Holding AG
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL NEUROPROTECTION MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL NEUROPROTECTION MARKET SIZE, BY APOPTOSIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL NEUROPROTECTION MARKET SIZE, BY FREE ANTI-INFLAMMATORY AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL NEUROPROTECTION MARKET SIZE, BY GLUTAMATE ANTAGONISTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL NEUROPROTECTION MARKET SIZE, BY METAL ION CHELATORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL NEUROPROTECTION MARKET SIZE, BY NEUROTROPHIC FACTORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL NEUROPROTECTION MARKET SIZE, BY RADICAL TRAPPING AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL NEUROPROTECTION MARKET SIZE, BY STIMULANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL NEUROPROTECTION MARKET SIZE, BY ALZHEIMER'S DISEASE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL NEUROPROTECTION MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL NEUROPROTECTION MARKET SIZE, BY BRAIN INJURY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL NEUROPROTECTION MARKET SIZE, BY HUNTINGTON'S DISEASE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL NEUROPROTECTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL NEUROPROTECTION MARKET SIZE, BY NEUROPATHIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL NEUROPROTECTION MARKET SIZE, BY OCULAR DEGENERATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL NEUROPROTECTION MARKET SIZE, BY PARKINSON'S DISEASE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL NEUROPROTECTION MARKET SIZE, BY PREVENTION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL NEUROPROTECTION MARKET SIZE, BY TREATMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AMERICAS NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AMERICAS NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ARGENTINA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. BRAZIL NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CANADA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. UNITED STATES NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ASIA-PACIFIC NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. ASIA-PACIFIC NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. AUSTRALIA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. AUSTRALIA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. AUSTRALIA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CHINA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CHINA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. CHINA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDIA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. INDIA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. INDIA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. INDONESIA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDONESIA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. INDONESIA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. JAPAN NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. JAPAN NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. JAPAN NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. MALAYSIA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. MALAYSIA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. MALAYSIA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. PHILIPPINES NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. PHILIPPINES NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. PHILIPPINES NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH KOREA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH KOREA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SOUTH KOREA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. THAILAND NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. THAILAND NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. THAILAND NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. FRANCE NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. FRANCE NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. FRANCE NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. GERMANY NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. GERMANY NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. GERMANY NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. ITALY NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. ITALY NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. ITALY NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. NETHERLANDS NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. NETHERLANDS NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. NETHERLANDS NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. QATAR NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. QATAR NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. QATAR NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. RUSSIA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. RUSSIA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. RUSSIA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SAUDI ARABIA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SAUDI ARABIA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SAUDI ARABIA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SOUTH AFRICA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. SOUTH AFRICA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. SOUTH AFRICA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. SPAIN NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SPAIN NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. SPAIN NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED ARAB EMIRATES NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. UNITED ARAB EMIRATES NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. UNITED ARAB EMIRATES NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. UNITED KINGDOM NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. UNITED KINGDOM NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. UNITED KINGDOM NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. GLOBAL NEUROPROTECTION MARKET: SCORES
TABLE 112. GLOBAL NEUROPROTECTION MARKET: BUSINESS STRATEGY
TABLE 113. GLOBAL NEUROPROTECTION MARKET: PRODUCT SATISFACTION
TABLE 114. GLOBAL NEUROPROTECTION MARKET: RANKING
TABLE 115. GLOBAL NEUROPROTECTION MARKET: MERGER & ACQUISITION
TABLE 116. GLOBAL NEUROPROTECTION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 117. GLOBAL NEUROPROTECTION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 118. GLOBAL NEUROPROTECTION MARKET: INVESTMENT & FUNDING
TABLE 119. GLOBAL NEUROPROTECTION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 120. GLOBAL NEUROPROTECTION MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL NEUROPROTECTION MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL NEUROPROTECTION MARKET SIZE, BY APOPTOSIS INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL NEUROPROTECTION MARKET SIZE, BY FREE ANTI-INFLAMMATORY AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL NEUROPROTECTION MARKET SIZE, BY GLUTAMATE ANTAGONISTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL NEUROPROTECTION MARKET SIZE, BY METAL ION CHELATORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL NEUROPROTECTION MARKET SIZE, BY NEUROTROPHIC FACTORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL NEUROPROTECTION MARKET SIZE, BY RADICAL TRAPPING AGENTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL NEUROPROTECTION MARKET SIZE, BY STIMULANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL NEUROPROTECTION MARKET SIZE, BY ALZHEIMER'S DISEASE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL NEUROPROTECTION MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL NEUROPROTECTION MARKET SIZE, BY BRAIN INJURY, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL NEUROPROTECTION MARKET SIZE, BY HUNTINGTON'S DISEASE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL NEUROPROTECTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL NEUROPROTECTION MARKET SIZE, BY NEUROPATHIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL NEUROPROTECTION MARKET SIZE, BY OCULAR DEGENERATION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL NEUROPROTECTION MARKET SIZE, BY PARKINSON'S DISEASE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL NEUROPROTECTION MARKET SIZE, BY PREVENTION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL NEUROPROTECTION MARKET SIZE, BY TREATMENT, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AMERICAS NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AMERICAS NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ARGENTINA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. BRAZIL NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CANADA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. UNITED STATES NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ASIA-PACIFIC NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. ASIA-PACIFIC NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. AUSTRALIA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. AUSTRALIA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. AUSTRALIA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CHINA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CHINA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. CHINA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDIA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. INDIA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. INDIA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. INDONESIA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDONESIA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. INDONESIA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. JAPAN NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. JAPAN NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. JAPAN NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. MALAYSIA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. MALAYSIA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. MALAYSIA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. PHILIPPINES NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. PHILIPPINES NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. PHILIPPINES NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH KOREA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH KOREA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SOUTH KOREA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. THAILAND NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. THAILAND NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. THAILAND NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. FRANCE NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. FRANCE NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. FRANCE NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. GERMANY NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. GERMANY NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. GERMANY NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. ITALY NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. ITALY NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. ITALY NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. NETHERLANDS NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. NETHERLANDS NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. NETHERLANDS NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. QATAR NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. QATAR NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. QATAR NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. RUSSIA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. RUSSIA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. RUSSIA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SAUDI ARABIA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SAUDI ARABIA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SAUDI ARABIA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SOUTH AFRICA NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. SOUTH AFRICA NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. SOUTH AFRICA NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. SPAIN NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SPAIN NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. SPAIN NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED ARAB EMIRATES NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. UNITED ARAB EMIRATES NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. UNITED ARAB EMIRATES NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. UNITED KINGDOM NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. UNITED KINGDOM NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. UNITED KINGDOM NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. GLOBAL NEUROPROTECTION MARKET: SCORES
TABLE 112. GLOBAL NEUROPROTECTION MARKET: BUSINESS STRATEGY
TABLE 113. GLOBAL NEUROPROTECTION MARKET: PRODUCT SATISFACTION
TABLE 114. GLOBAL NEUROPROTECTION MARKET: RANKING
TABLE 115. GLOBAL NEUROPROTECTION MARKET: MERGER & ACQUISITION
TABLE 116. GLOBAL NEUROPROTECTION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 117. GLOBAL NEUROPROTECTION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 118. GLOBAL NEUROPROTECTION MARKET: INVESTMENT & FUNDING
TABLE 119. GLOBAL NEUROPROTECTION MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 120. GLOBAL NEUROPROTECTION MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL NEUROPROTECTION MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL NEUROPROTECTION MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL NEUROPROTECTION MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 5. GLOBAL NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
FIGURE 7. GLOBAL NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL NEUROPROTECTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL NEUROPROTECTION MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL NEUROPROTECTION MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 15. GLOBAL NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2025
FIGURE 17. GLOBAL NEUROPROTECTION MARKET SIZE, BY APOPTOSIS INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL NEUROPROTECTION MARKET SIZE, BY FREE ANTI-INFLAMMATORY AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL NEUROPROTECTION MARKET SIZE, BY GLUTAMATE ANTAGONISTS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL NEUROPROTECTION MARKET SIZE, BY METAL ION CHELATORS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL NEUROPROTECTION MARKET SIZE, BY NEUROTROPHIC FACTORS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL NEUROPROTECTION MARKET SIZE, BY RADICAL TRAPPING AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL NEUROPROTECTION MARKET SIZE, BY STIMULANTS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
FIGURE 25. GLOBAL NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2025
FIGURE 27. GLOBAL NEUROPROTECTION MARKET SIZE, BY ALZHEIMER'S DISEASE, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL NEUROPROTECTION MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL NEUROPROTECTION MARKET SIZE, BY BRAIN INJURY, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL NEUROPROTECTION MARKET SIZE, BY HUNTINGTON'S DISEASE, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL NEUROPROTECTION MARKET SIZE, BY MULTIPLE SCLEROSIS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL NEUROPROTECTION MARKET SIZE, BY NEUROPATHIES, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL NEUROPROTECTION MARKET SIZE, BY OCULAR DEGENERATION, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL NEUROPROTECTION MARKET SIZE, BY PARKINSON'S DISEASE, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 36. GLOBAL NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2025
FIGURE 38. GLOBAL NEUROPROTECTION MARKET SIZE, BY PREVENTION, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
FIGURE 40. AMERICAS NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. AMERICAS NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. ARGENTINA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. BRAZIL NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. CANADA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. MEXICO NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. UNITED STATES NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. ASIA-PACIFIC NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 49. ASIA-PACIFIC NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 51. AUSTRALIA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. CHINA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. INDIA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. INDONESIA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. JAPAN NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. MALAYSIA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. PHILIPPINES NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SOUTH KOREA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. THAILAND NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 63. FRANCE NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. GERMANY NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. ITALY NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. NETHERLANDS NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. QATAR NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. RUSSIA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SAUDI ARABIA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SOUTH AFRICA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. SPAIN NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. UNITED ARAB EMIRATES NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. UNITED KINGDOM NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. GLOBAL NEUROPROTECTION MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 75. GLOBAL NEUROPROTECTION MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 76. GLOBAL NEUROPROTECTION MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NEUROPROTECTION MARKET, BY TYPE
FIGURE 1. GLOBAL NEUROPROTECTION MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL NEUROPROTECTION MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL NEUROPROTECTION MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 5. GLOBAL NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
FIGURE 7. GLOBAL NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL NEUROPROTECTION MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL NEUROPROTECTION MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL NEUROPROTECTION MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 15. GLOBAL NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPROTECTION MARKET SIZE, BY PRODUCT, 2025
FIGURE 17. GLOBAL NEUROPROTECTION MARKET SIZE, BY APOPTOSIS INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL NEUROPROTECTION MARKET SIZE, BY FREE ANTI-INFLAMMATORY AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL NEUROPROTECTION MARKET SIZE, BY GLUTAMATE ANTAGONISTS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL NEUROPROTECTION MARKET SIZE, BY METAL ION CHELATORS, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL NEUROPROTECTION MARKET SIZE, BY NEUROTROPHIC FACTORS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL NEUROPROTECTION MARKET SIZE, BY RADICAL TRAPPING AGENTS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL NEUROPROTECTION MARKET SIZE, BY STIMULANTS, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
FIGURE 25. GLOBAL NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2025
FIGURE 27. GLOBAL NEUROPROTECTION MARKET SIZE, BY ALZHEIMER'S DISEASE, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL NEUROPROTECTION MARKET SIZE, BY AMYOTROPHIC LATERAL SCLEROSIS, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL NEUROPROTECTION MARKET SIZE, BY BRAIN INJURY, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL NEUROPROTECTION MARKET SIZE, BY HUNTINGTON'S DISEASE, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL NEUROPROTECTION MARKET SIZE, BY MULTIPLE SCLEROSIS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL NEUROPROTECTION MARKET SIZE, BY NEUROPATHIES, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL NEUROPROTECTION MARKET SIZE, BY OCULAR DEGENERATION, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL NEUROPROTECTION MARKET SIZE, BY PARKINSON'S DISEASE, 2020 VS 2025 (USD MILLION)
FIGURE 35. GLOBAL NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 36. GLOBAL NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NEUROPROTECTION MARKET SIZE, BY APPLICATION, 2025
FIGURE 38. GLOBAL NEUROPROTECTION MARKET SIZE, BY PREVENTION, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL NEUROPROTECTION MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
FIGURE 40. AMERICAS NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. AMERICAS NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. ARGENTINA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. BRAZIL NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. CANADA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. MEXICO NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. UNITED STATES NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. ASIA-PACIFIC NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 49. ASIA-PACIFIC NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 51. AUSTRALIA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. CHINA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. INDIA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. INDONESIA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. JAPAN NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. MALAYSIA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. PHILIPPINES NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SOUTH KOREA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. THAILAND NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 63. FRANCE NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. GERMANY NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. ITALY NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. NETHERLANDS NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. QATAR NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. RUSSIA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SAUDI ARABIA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SOUTH AFRICA NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. SPAIN NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. UNITED ARAB EMIRATES NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. UNITED KINGDOM NEUROPROTECTION MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. GLOBAL NEUROPROTECTION MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 75. GLOBAL NEUROPROTECTION MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 76. GLOBAL NEUROPROTECTION MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NEUROPROTECTION MARKET, BY TYPE
